Captopril and Upper gastrointestinal haemorrhage - a phase IV clinical study of FDA data

Summary:

Upper gastrointestinal haemorrhage is reported as a side effect among people who take Captopril (captopril), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Upper gastrointestinal haemorrhage when taking Captopril. It is created by eHealthMe based on reports of 17,289 people who have side effects when taking Captopril from the FDA, and is updated regularly.

What is Captopril?

Captopril has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 17,438 Captopril users. Check the latest studies of Captopril.

What is Upper gastrointestinal haemorrhage?

Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding) is found to be associated with 1,024 drugs and 1,017 conditions by eHealthMe. Check the latest studies of Upper gastrointestinal haemorrhage.

On Jul, 16, 2026

17,289 people reported to have side effects when taking Captopril.
Among them, 59 people (0.34%) have Upper gastrointestinal haemorrhage.

Could Captopril cause Upper gastrointestinal haemorrhage?

Among these 59 people:

How long have people been on Captopril when they have Upper gastrointestinal haemorrhage? *

What is the gender of people who have Upper gastrointestinal haemorrhage when taking Captopril? *

female: 50 %
male: 50 %

What is the age of people who have Upper gastrointestinal haemorrhage when taking Captopril? *

What are other drugs people take besides Captopril? *

What are other side effects people have besides Upper gastrointestinal haemorrhage? *

Heart Attack: 12 people, 20.34%
Anaemia (lack of blood): 10 people, 16.95%
Presyncope: 9 people, 15.25%
Dyskinesia (abnormality or impairment of voluntary movement): 9 people, 15.25%
Haemoglobin Decreased: 8 people, 13.56%
Abdominal Pain Upper: 8 people, 13.56%
Thrombocytopenia (decrease of platelets in blood): 8 people, 13.56%
Loss Of Consciousness: 8 people, 13.56%
Haematemesis (vomiting of blood): 8 people, 13.56%
Melaena (the passage of black, tarry stools): 7 people, 11.86%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 16.95%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 15.25%
Nausea And Vomiting: 7 people, 11.86%
Back Pain: 7 people, 11.86%
Chills (felling of cold): 7 people, 11.86%
Constipation: 7 people, 11.86%
Diarrhea: 7 people, 11.86%
Fever: 7 people, 11.86%
Nausea (feeling of having an urge to vomit): 7 people, 11.86%
Blood Potassium Decreased: 6 people, 10.17%

* Approximation only. Some reports may have incomplete information.

Do you take Captopril and have Upper gastrointestinal haemorrhage?

- Check whether Upper gastrointestinal haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Captopril:

Captopril (17,438 reports)

Browse all side effects of Captopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Upper gastrointestinal haemorrhage:

Upper gastrointestinal haemorrhage (1,024 drugs)

Browse all the conditions that are associated with Upper gastrointestinal haemorrhage:

Upper gastrointestinal haemorrhage (1,017 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on captopril (the active ingredients of Captopril) and Captopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.